These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

140 related items for PubMed ID: 7911139

  • 1. Contribution of serotonin neurotoxins to understanding psychiatric disorders: the role of 5-HT2 receptors in schizophrenia and antipsychotic activity.
    Schmidt CJ, Kehne JH, Carr AA, Fadayel GM, Humphreys TM, Kettler HJ, McCloskey TC, Padich RA, Taylor VL, Sorensen SM.
    Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():25-32. PubMed ID: 7911139
    [No Abstract] [Full Text] [Related]

  • 2. [Dopamine D2 and serotonin 5HT2 receptors: functions, interactions and clinical consequences in schizophrenia].
    Guise S, Soubrouillard C, Blin O.
    Encephale; 1997 Apr; 23 Spec No 2():10-6. PubMed ID: 9273300
    [Abstract] [Full Text] [Related]

  • 3. [Neuroleptics and serotonin].
    Hery F, Hamon M.
    Encephale; 1993 Apr; 19(5):525-32. PubMed ID: 7905821
    [Abstract] [Full Text] [Related]

  • 4. Depression to ecstasy. The Neuropharmacology of Serotonin sponsored by the New York Academy of Sciences, New York, NY, USA, July 10-13, 1989.
    Whitaker-Azmitia PM.
    New Biol; 1989 Nov; 1(2):145-8. PubMed ID: 2577368
    [No Abstract] [Full Text] [Related]

  • 5. Ecstasy: towards an understanding of the biochemical basis of the actions of MDMA.
    Rattray M.
    Essays Biochem; 1991 Nov; 26():77-87. PubMed ID: 1685707
    [No Abstract] [Full Text] [Related]

  • 6. [Psychopharmacologic approaches to schizophrenic psychoses].
    Giacardy-Paty M, Soubrouillard C, Blin O.
    Encephale; 1995 Jun; 21 Spec No 3():3-8. PubMed ID: 7628339
    [Abstract] [Full Text] [Related]

  • 7. The psychopharmacology of ziprasidone: receptor-binding properties and real-world psychiatric practice.
    Stahl SM, Shayegan DK.
    J Clin Psychiatry; 2003 Jun; 64 Suppl 19():6-12. PubMed ID: 14728084
    [Abstract] [Full Text] [Related]

  • 8. Conventional versus novel antipsychotics: changing concepts and clinical implications.
    Remington G, Chong SA.
    J Psychiatry Neurosci; 1999 Nov; 24(5):431-41. PubMed ID: 10586534
    [Abstract] [Full Text] [Related]

  • 9. Schizophrenia: into the next millennium.
    Jones B.
    Can J Psychiatry; 1993 Sep; 38 Suppl 3():S67-9. PubMed ID: 7902776
    [Abstract] [Full Text] [Related]

  • 10. The neurobiology of cognition in schizophrenia.
    Tamminga CA.
    J Clin Psychiatry; 2006 Sep; 67 Suppl 9():9-13; discussion 36-42. PubMed ID: 16965183
    [Abstract] [Full Text] [Related]

  • 11. Serotonin receptor responsivity in schizophrenia.
    Kahn RS, Davidson M.
    Int Clin Psychopharmacol; 1993 Nov; 8 Suppl 2():47-51. PubMed ID: 7911140
    [No Abstract] [Full Text] [Related]

  • 12. The neurochemical circuitry of schizophrenia.
    Carlsson A.
    Pharmacopsychiatry; 2006 Feb; 39 Suppl 1():S10-4. PubMed ID: 16508890
    [Abstract] [Full Text] [Related]

  • 13. Perspectives on the role of serotonergic mechanisms in the pharmacology of schizophrenia.
    Seibyl JP.
    J Psychopharmacol; 1997 Feb; 11(2):188-9. PubMed ID: 9208382
    [No Abstract] [Full Text] [Related]

  • 14. Neurotoxicity of MDMA: neurochemical effects.
    Schmidt CJ, Kehne JH.
    Ann N Y Acad Sci; 1990 Feb; 600():665-80; discussion 680-1. PubMed ID: 1979217
    [No Abstract] [Full Text] [Related]

  • 15. [Ecstasy--effects and toxicity. Distinct risks but uncertain long-term hazards].
    Series H, Lindefors N.
    Lakartidningen; 1993 Aug 11; 90(32-33):2648-52. PubMed ID: 8103135
    [No Abstract] [Full Text] [Related]

  • 16. The neurobiology of cognition in schizophrenia.
    Tamminga CA.
    J Clin Psychiatry; 2006 Sep 11; 67(9):e11. PubMed ID: 17081078
    [Abstract] [Full Text] [Related]

  • 17. Alterations of serotonin transmission in schizophrenia.
    Abi-Dargham A.
    Int Rev Neurobiol; 2007 Sep 11; 78():133-64. PubMed ID: 17349860
    [Abstract] [Full Text] [Related]

  • 18. Effects of antipsychotic drugs on serotonin receptors.
    Meltzer HY, Nash JF.
    Pharmacol Rev; 1991 Dec 11; 43(4):587-604. PubMed ID: 1685568
    [No Abstract] [Full Text] [Related]

  • 19. [Schizophrenia: receptors and clinical aspects].
    Azorin JM.
    Encephale; 1997 Apr 11; 23 Spec No 2():17-9. PubMed ID: 9273301
    [Abstract] [Full Text] [Related]

  • 20. [The involvement of 5-HT1a serotonin receptors in the pathophysiology and pharmacotherapy of schizophrenia].
    Maćkowiak M, Czyrak A, Wedzony K.
    Psychiatr Pol; 2000 Apr 11; 34(4):607-21. PubMed ID: 11059260
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.